Picton Mahoney Asset Management’s Exact Sciences EXAS Stock Holding History

Picton Mahoney Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200,000	Closed	-$20.3M	–	1302
2025 Q4	$20.3M	Buy	+200,000	New	+$16.1M	0.16%	113

Other funds holding EXAS

VanEck Associates

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Picton Mahoney Asset Management's EXAS Position: Q1 2026 in Review

Picton Mahoney Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 400,000 shares — an estimated $40.6M sold.

Picton Mahoney Asset Management first reported a position in EXAS in Q3 2020 and held it in 6 quarters. The position peaked at $40.6M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Picton Mahoney Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Picton Mahoney Asset Management sold 400,000 Exact Sciences shares in Q1 2026, an estimated $40.6M.
Picton Mahoney Asset Management first reported a position in Exact Sciences in Q3 2020 and held it in 6 quarters.
Picton Mahoney Asset Management's Exact Sciences position peaked at $40.6M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.